AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Colorado Bio-Technology Firm Wins TiE-Rockies Next Great Idea Competition; MicroPhage Inc. Edges Two Other Colorado Companies To Win Inaugural Business Plan Competition.
Business Editors
DENVER--(BUSINESS WIRE)--Sept. 18, 2003
MicroPhage, Inc., a Golden-based company developing high-speed bacteria detection technologies, has been named the winner of "The Next Great Idea: TiE-Rockies' Search for Tomorrow's Technology Business," a region-wide competition to identify and help develop the best new technology business concepts in the Rocky Mountains.
MicroPhage was selected by a panel of prominent national venture capitalist firms at an event at the Pepsi Center in downtown Denver Tuesday night chaired by John Hansen, Secretary of Technology for the State of Colorado and attended by over 120 business leaders from around Colorado. MicroPhage edged out two other Colorado companies after each company presented its business plan live to the panel and the audience. Secretary Hansen announced the winner at the conclusion of the event.
"We are very proud to have MicroPhage as the inaugural winner of the Next Great Idea Competition," said Vipanj Patel, president of TiE-Rockies. "The purpose of the competition was to identify and celebrate the great entrepreneurial efforts in Colorado and the quality of the finalists reflects that intention. It's just unfortunate we could only have one winner."
MicroPhage, based in Golden, Colo., at the Colorado School of Mines, develops high-speed bacteria detection technologies that it plans to commercialize in markets including food safety, environment contamination, water safety, evaluation of infectious agents in humans and animals, industrial pathogens, biological warfare threat agents, and other clinical applications.
"This is a great honor and a validation of MicroPhage's vision," said John H. Wheeler, CEO of MicroPhage. "The competition and the great companies it identified demonstrate the wealth of business ideas and entrepreneurial spirit in Colorado. We are very pleased to serve as the inaugural winner of the TiE-Rockies' competition."
- MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test.
- Press release article from: PR Newswire January 13, 2009 700+ words
...clinical trial, which was announced today by MicroPhage, Inc., http://www.microphage.com/. The company also reported the trial...AQTU542) The beta-site study evaluated MicroPhage's prototype assay to identify Staphylococcus...
- New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious...
- Press release article from: PR Newswire November 18, 2008 700+ words
...developmental diagnostic assay produced by MicroPhage, Inc., http://www.microphage.com/, was shown to be highly accurate...Chemotherapy (ICAAC). In the first presentation, MicroPhage scientists reported that their novel platform...
- Former Premier CEO Richard Norling to Join MicroPhage Board of Directors.
- Press release article from: Business Wire October 13, 2009 700+ words
...Respected Healthcare Executive Joins as MicroPhage Prepares for Commercial Launch LONGMONT, Colo. -- MicroPhage, Inc. today announced it named Richard...This insight will be important for MicroPhage as we position our innovative and more...
- MicroPhage Selects Lynn Taussig, MD for Board of Directors.
- Press release article from: PR Newswire December 2, 2008 700+ words
...LONGMONT, Colo., Dec. 2 /PRNewswire/ -- MicroPhage, Inc., http://www.microphage.com/, announced today that Lynn M. Taussig...pediatric pulmonology. "I have followed MicroPhage extensively and am impressed with its progress...
- MicroPhage Closes Latest Financing.
- Press release article from: PR Newswire November 20, 2008 700+ words
...LONGMONT, Colo., Nov. 20 /PRNewswire/ -- MicroPhage, Inc., http://www.microphage.com/, today announced it has concluded...to date have come from private investors. MicroPhage will apply proceeds of its financing to complete...
- MicroPhage Demonstrates Rapid Diagnostic Platform Feasibility in Skin and Soft...
- Newspaper article from: Biotech Week June 3, 2009 700+ words
...inexpensive developmental diagnostic assay produced by MicroPhage, Inc., www.microphage.com, was shown to be highly accurate for...from skin and soft tissue infections (see also MicroPhage, Inc.). Thirty three samples from a wide...
- MicroPhage, Inc. Raises Additional Funding to Respond to 'Superbug Crisis'.
- Press release article from: Business Wire October 17, 2007 700+ words
...contracting it from inside their facilities. MicroPhage, Inc., an early stage medical diagnostics...to other hospitalized patients. The MicroPhage test uses bacteriophages, the natural...replicate. It is this replication that MicroPhage uses to determine MRSA quickly and efficiently...
- MicroPhage Opens Pivotal FDA Study on Bacterial Identification Platform.
- Press release article from: Business Wire August 20, 2009 700+ words
LONGMONT, Colo. -- MicroPhage announced today the launch of its...infections takes up to three days. The MicroPhage test platform requires no instrumentation...its safety and performance. The MicroPhage test will be compared to a laboratory...